Privia Health Group (PRVA) Competitors

$22.59 -0.47 (-2.06%)

As of 02:53 PM Eastern

PRVA vs. GH, FMS, BTSG, CELC, and HIMS

Should you be buying Privia Health Group stock or one of its competitors? The main competitors of Privia Health Group include Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), BrightSpring Health Services (BTSG), Celcuity (CELC), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry.

How does Privia Health Group compare to Guardant Health?

Privia Health Group (NASDAQ:PRVA) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, profitability, valuation, institutional ownership and risk.

Privia Health Group has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.48, indicating that its share price is 48% more volatile than the S&P 500.

Privia Health Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.12B	1.34	$22.92M	$0.16	141.16
Guardant Health	$1.08B	11.82	-$416.28M	-$3.39	N/A

Privia Health Group has a net margin of 0.97% compared to Guardant Health's net margin of -40.10%. Privia Health Group's return on equity of 2.81% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	0.97%	2.81%	1.61%
Guardant Health	-40.10%	N/A	-26.42%

In the previous week, Privia Health Group had 11 more articles in the media than Guardant Health. MarketBeat recorded 28 mentions for Privia Health Group and 17 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.59 beat Privia Health Group's score of 0.38 indicating that Guardant Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	10 Very Positive mention(s)	0 Positive mention(s)	10 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Guardant Health	5 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by company insiders. Comparatively, 6.1% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Privia Health Group presently has a consensus price target of $31.23, indicating a potential upside of 38.27%. Guardant Health has a consensus price target of $129.16, indicating a potential upside of 34.09%. Given Privia Health Group's higher probable upside, equities research analysts plainly believe Privia Health Group is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
Guardant Health	1 Sell rating(s)	1 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.86

Summary

Privia Health Group beats Guardant Health on 10 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Privia Health Group (NASDAQ:PRVA) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends.

Fresenius Medical Care AG & Co. KGaA currently has a consensus price target of $28.00, indicating a potential upside of 28.56%. Privia Health Group has a consensus price target of $31.23, indicating a potential upside of 38.27%. Given Privia Health Group's stronger consensus rating and higher probable upside, analysts plainly believe Privia Health Group is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Fresenius Medical Care AG & Co. KGaA has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500.

In the previous week, Privia Health Group had 12 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 28 mentions for Privia Health Group and 16 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.62 beat Privia Health Group's score of 0.38 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	5 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive
Privia Health Group	10 Very Positive mention(s)	0 Positive mention(s)	10 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Privia Health Group's net margin of 0.97%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%
Privia Health Group	0.97%	2.81%	1.61%

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. Comparatively, 94.5% of Privia Health Group shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Privia Health Group. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$19.36B	0.63	$1.11B	$1.90	11.46
Privia Health Group	$2.12B	1.34	$22.92M	$0.16	141.16

Summary

Privia Health Group beats Fresenius Medical Care AG & Co. KGaA on 9 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to BrightSpring Health Services?

Privia Health Group (NASDAQ:PRVA) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation, risk and media sentiment.

In the previous week, Privia Health Group had 16 more articles in the media than BrightSpring Health Services. MarketBeat recorded 28 mentions for Privia Health Group and 12 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.84 beat Privia Health Group's score of 0.38 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	10 Very Positive mention(s)	0 Positive mention(s)	10 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
BrightSpring Health Services	5 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

BrightSpring Health Services has a net margin of 2.27% compared to Privia Health Group's net margin of 0.97%. BrightSpring Health Services' return on equity of 14.63% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	0.97%	2.81%	1.61%
BrightSpring Health Services	2.27%	14.63%	4.41%

Privia Health Group has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500. Comparatively, BrightSpring Health Services has a beta of 1.71, indicating that its stock price is 71% more volatile than the S&P 500.

BrightSpring Health Services has higher revenue and earnings than Privia Health Group. BrightSpring Health Services is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.12B	1.34	$22.92M	$0.16	141.16
BrightSpring Health Services	$12.91B	0.82	$190.67M	$1.41	38.74

94.5% of Privia Health Group shares are held by institutional investors. 5.7% of Privia Health Group shares are held by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Privia Health Group presently has a consensus price target of $31.23, suggesting a potential upside of 38.27%. BrightSpring Health Services has a consensus price target of $56.29, suggesting a potential upside of 3.04%. Given Privia Health Group's higher probable upside, analysts clearly believe Privia Health Group is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	2 Strong Buy rating(s)	3.12

Summary

BrightSpring Health Services beats Privia Health Group on 11 of the 17 factors compared between the two stocks.

How does Privia Health Group compare to Celcuity?

Celcuity (NASDAQ:CELC) and Privia Health Group (NASDAQ:PRVA) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.

63.3% of Celcuity shares are held by institutional investors. Comparatively, 94.5% of Privia Health Group shares are held by institutional investors. 13.3% of Celcuity shares are held by insiders. Comparatively, 5.7% of Privia Health Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Privia Health Group had 2 more articles in the media than Celcuity. MarketBeat recorded 28 mentions for Privia Health Group and 26 mentions for Celcuity. Celcuity's average media sentiment score of 0.43 beat Privia Health Group's score of 0.38 indicating that Celcuity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	8 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Privia Health Group	10 Very Positive mention(s)	0 Positive mention(s)	10 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Celcuity has a beta of 0.09, indicating that its share price is 91% less volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500.

Celcuity presently has a consensus price target of $134.50, suggesting a potential upside of 6.39%. Privia Health Group has a consensus price target of $31.23, suggesting a potential upside of 38.27%. Given Privia Health Group's stronger consensus rating and higher probable upside, analysts clearly believe Privia Health Group is more favorable than Celcuity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.75
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Privia Health Group has a net margin of 0.97% compared to Celcuity's net margin of 0.00%. Privia Health Group's return on equity of 2.81% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-203.17%	-52.68%
Privia Health Group	0.97%	2.81%	1.61%

Privia Health Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.79	N/A
Privia Health Group	$2.12B	1.34	$22.92M	$0.16	141.16

Summary

Privia Health Group beats Celcuity on 13 of the 15 factors compared between the two stocks.

How does Privia Health Group compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Privia Health Group (NASDAQ:PRVA) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, media sentiment and profitability.

Hims & Hers Health has a beta of 2.43, suggesting that its stock price is 143% more volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500.

In the previous week, Privia Health Group had 5 more articles in the media than Hims & Hers Health. MarketBeat recorded 28 mentions for Privia Health Group and 23 mentions for Hims & Hers Health. Hims & Hers Health's average media sentiment score of 0.84 beat Privia Health Group's score of 0.38 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	10 Very Positive mention(s)	9 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Privia Health Group	10 Very Positive mention(s)	0 Positive mention(s)	10 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 94.5% of Privia Health Group shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Comparatively, 5.7% of Privia Health Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Hims & Hers Health has a net margin of 5.47% compared to Privia Health Group's net margin of 0.97%. Hims & Hers Health's return on equity of 22.48% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	5.47%	22.48%	7.02%
Privia Health Group	0.97%	2.81%	1.61%

Hims & Hers Health currently has a consensus target price of $31.86, suggesting a potential upside of 6.64%. Privia Health Group has a consensus target price of $31.23, suggesting a potential upside of 38.27%. Given Privia Health Group's stronger consensus rating and higher possible upside, analysts plainly believe Privia Health Group is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.18
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Hims & Hers Health has higher revenue and earnings than Privia Health Group. Hims & Hers Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.90	$128.37M	$0.51	58.57
Privia Health Group	$2.12B	1.34	$22.92M	$0.16	141.16

Summary

Hims & Hers Health beats Privia Health Group on 10 of the 16 factors compared between the two stocks.

Get Privia Health Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PRVA vs. The Competition

Export

Metric	Privia Health Group	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.83B	$1.47B	$6.20B	$12.30B
Dividend Yield	N/A	N/A	2.78%	5.22%
P/E Ratio	140.45	65.44	20.71	25.86
Price / Sales	1.34	5.84	549.99	74.51
Price / Cash	86.41	23.91	27.81	36.27
Price / Book	3.51	4.81	9.82	6.79
Net Income	$22.92M	-$54.76M	$3.55B	$333.31M
7 Day Performance	N/A	N/A	N/A	0.56%
1 Month Performance	0.97%	12.23%	6.77%	9.42%
1 Year Performance	-9.73%	0.17%	42.65%	43.23%

Privia Health Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PRVA Privia Health Group	4.0574 of 5 stars	$22.59 -2.1%	$31.23 +38.3%	-7.7%	$2.83B	$2.12B	140.45	1,226	Earnings Report Analyst Forecast
GH Guardant Health	3.9737 of 5 stars	$88.05 -3.4%	$128.63 +46.1%	+129.4%	$11.67B	$982.02M	N/A	2,506	Analyst Forecast
FMS Fresenius Medical Care AG & Co. KGaA	4.6618 of 5 stars	$20.33 -10.3%	$28.00 +37.8%	-22.4%	$11.35B	$19.63B	10.64	1,488	Earnings Report Analyst Downgrade High Trading Volume
BTSG BrightSpring Health Services	3.3665 of 5 stars	$52.92 -1.2%	$55.29 +4.5%	+140.3%	$10.22B	$12.91B	37.53	23,500	Analyst Upgrade
CELC Celcuity	1.5011 of 5 stars	$142.73 -1.6%	$134.50 -5.8%	+1,191.2%	$6.90B	N/A	N/A	40	Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PRVA) was last updated on 5/11/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Privia Health Group (PRVA) Competitors

PRVA vs. GH, FMS, BTSG, CELC, and HIMS

How does Privia Health Group compare to Guardant Health?

Summary

How does Privia Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Privia Health Group compare to BrightSpring Health Services?

Summary

How does Privia Health Group compare to Celcuity?

Summary

How does Privia Health Group compare to Hims & Hers Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRVA vs. The Competition

Privia Health Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Privia Health Group (PRVA) Competitors

PRVA vs. GH, FMS, BTSG, CELC, and HIMS

How does Privia Health Group compare to Guardant Health?

Which has more volatility & risk, PRVA or GH?

Which has preferable earnings & valuation, PRVA or GH?

Is PRVA or GH more profitable?

Does the media refer more to PRVA or GH?

Do institutionals & insiders believe in PRVA or GH?

Do analysts prefer PRVA or GH?

Summary

How does Privia Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Do analysts recommend FMS or PRVA?

Which has more volatility & risk, FMS or PRVA?

Does the media prefer FMS or PRVA?

Is FMS or PRVA more profitable?

Do institutionals and insiders believe in FMS or PRVA?

Which has stronger valuation and earnings, FMS or PRVA?

Summary

How does Privia Health Group compare to BrightSpring Health Services?

Does the media refer more to PRVA or BTSG?

Is PRVA or BTSG more profitable?

Which has more volatility and risk, PRVA or BTSG?

Which has stronger earnings & valuation, PRVA or BTSG?

Do insiders and institutionals have more ownership in PRVA or BTSG?

Do analysts rate PRVA or BTSG?

Summary

How does Privia Health Group compare to Celcuity?

Do institutionals and insiders have more ownership in CELC or PRVA?

Does the media prefer CELC or PRVA?

Which has more risk and volatility, CELC or PRVA?

Do analysts recommend CELC or PRVA?

Is CELC or PRVA more profitable?

Which has higher earnings and valuation, CELC or PRVA?

Summary

How does Privia Health Group compare to Hims & Hers Health?

Which has more risk & volatility, HIMS or PRVA?

Does the media prefer HIMS or PRVA?

Do insiders & institutionals have more ownership in HIMS or PRVA?

Is HIMS or PRVA more profitable?

Do analysts recommend HIMS or PRVA?

Which has stronger valuation & earnings, HIMS or PRVA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRVA vs. The Competition

Privia Health Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools